Exploring scalable, data-driven AAV manufacturing to achieve high yield and quality across serotypes
Xiaojun Liu, Chris Brown, Yeonji Kim
Exploring key regulatory considerations to ensure patient safety in the gene therapy space
L Shaw, C Le Bec, M Orio et al
Actionable insights for overcoming CMC challenges in TIL therapy: GRIT’s strategic approach
Alex Lei, Sabrina Carmichael
Optimizing iPSC therapies: strategies for safe, cost-effective, and scalable manufacturing
K Bruce, K Bharti, I Barbaric et al
Conducting rapid microbiological monitoring in fill-finish with biofluorescent particle counters: a collaborative case study
M Dingle, A Carwell, M J. Miller et al
GMP or not? Understanding raw material quality grades and requirements for ATMP manufacturing
Lili Belcastro, Basak Clements, Claire Wartel
Modernizing viral clearance study strategy: regulatory updates and industry best practices
Audrey Chang, Kathleen Kenney
From concept to clinic: overcoming the challenges of potency assays in cell and gene therapy development
Audrey Chang, Joe Newcome
